Literature DB >> 12778968

Generating recombinant anti-idiotypic antibodies for the detection of haptens in solution.

Jos Raats1, Nicole van Bree, Jochem van Woezik, Ger Pruijn.   

Abstract

A new method is described for generating recombinant human and chicken antibody fragments for accurate quantification of haptens in solution. The chemistry of labelling small molecules has always been a problem in the development of immunoassays. Here, we describe a specific panning procedure that enables the selection of recombinant anti-idiotypic phage antibodies that bind to hapten binding molecules (e.g., antibodies) in the absence of the hapten, but are displaced in a highly specific and concentration dependent manner, in the presence of the hapten. The major advantage of such a detection system is that there is no need to label the hapten or to covalently attach it to a solid phase. In this study we demonstrate, using cortisol and aldosterone as model haptens, that the recombinant antibody phage display technology offers great possibilities to generate recombinant anti-idiotypic antibodies. Furthermore, we show that such antibodies can be used successfully to design highly sensitive immunoassays for the quantification of small molecules.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12778968     DOI: 10.1081/IAS-120020081

Source DB:  PubMed          Journal:  J Immunoassay Immunochem        ISSN: 1532-1819


  3 in total

Review 1.  Phage display: a powerful technology for the generation of high specificity affinity reagents from alternative immune sources.

Authors:  William J J Finlay; Laird Bloom; Orla Cunningham
Journal:  Methods Mol Biol       Date:  2011

2.  Phage Display: A Powerful Technology for the Generation of High-Specificity Affinity Reagents from Alternative Immune Sources.

Authors:  William J J Finlay; Laird Bloom; Joanne Grant; Edward Franklin; Deirdre Ní Shúilleabháin; Orla Cunningham
Journal:  Methods Mol Biol       Date:  2017

3.  Efficient, chemoselective synthesis of immunomicelles using single-domain antibodies with a C-terminal thioester.

Authors:  Sanne W A Reulen; Ingrid van Baal; Jos M H Raats; Maarten Merkx
Journal:  BMC Biotechnol       Date:  2009-07-20       Impact factor: 2.563

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.